ARCH Venture Partners VIII, LLC
SEC CIK 1616165 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NMRA | Neumora Therapeutics, Inc. | 10% | 6.05M | $30.50M | — | 3 | 2023-09-19 | 2025-10-27 |
Most active insiders at NMRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ARCH Venture Partners XII, LLC | 10% | $5.00M | — |
| 2 | ARCH Venture Partners VIII, LLC | 10% | $5.00M | — |
| 3 | Burow Kristina | Dir, 10% | $5.00M | — |
| 4 | Aurora Daljit Singh | See Remarks | — | $1.03M |
| 5 | BERNS PAUL L | See Remarks, Dir | — | $34.5K |
| 6 | Pinto Joshua | Pres | — | $21.1K |
| 7 | Milligan Michael Lee | See Remarks | — | $5,127 |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-10-29 | 2025-10-27 | NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners VIII, LLC | 10% | P - Purchase | $2.61 | +1.92M | 6.05M | +46% | +$5.00M |
| DI | 2023-09-20 | 2023-09-19 | NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners VIII, LLC | 10% | P - Purchase | $17.00 | +1.50M | 3.62M | +71% | +$25.50M |
| DMI | 2023-09-20 | 2023-09-19 | NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners VIII, LLC | 10% | C - Cnv Deriv | — | +17.42M | 684.2K | New | — |
Purchase Sale Sale after option exercise All abbreviations